Fourier Intelligence Inks Industry-Academic Partnership with The University of Queensland

The public research university forges an agreement with the SoftBank-backed rehab robotics leader, Fourier Intelligence

SINGAPORE, April 11, 2022 – Fourier Intelligence announces its partnership with The University of Queensland (UQ). The partnership was inked to deliver research for personalised robotic therapy for restoration of walking function after stroke combining Fourier Intelligence’s EXOPS™, and UQ’s expertise in Neuroengineering, Rehabilitation, Medical Robotics, and Artificial Intelligence.

The project, led by Dr Alejandro Melendez-Calderon (UQ), involves a transdisciplinary research team of Biomedical and Rehabilitation Engineers, Scientists, and Clinicians across multiple faculties and institutes and aims at co-developing robot-assisted methods for promoting recovery, suited to the Australian healthcare system.

A virtual signing was held on the 6^th of April 2022 to commemorate the partnership between Fourier Intelligence and UQ. The virtual signing ceremony was attended by Zen Koh, Co-Founder and Group Deputy CEO, CEO of Global HQ, Owen Teoh, General Manager, Sarah Lim, Assistant Director of Support Services, Taya Hamilton, Clinical Consultant, Oceanic Region, Chen Onn Leong, Manager for Scientific Research from Fourier Intelligence; Prof. Denny Oetomo, co-director of the University of Melbourne & Fourier Robotics Laboratory; and Lisa Kennedy, Director of Research Partnerships, and Dr Alejandro Melendez-Calderon, Principal Investigator, from The University of Queensland.

With this partnership, The University of Queensland will become part of the Global Rehabilitation & Assistive Technology (GReAT) Network – an international association between top academic and clinical institutions around the world to optimise resource sharing and knowledge transfer in assistive and rehabilitation technologies. The goal is to facilitate the efforts of engineers, academics, and clinical stakeholders focused on translational research from early research and development stages into clinical adoption.

The team is leveraging capabilities created by the UQ Artificial Intelligence (AI) Collaboratory Initiative and Fourier Intelligence’s unique  EXOPS™ platform combined with the company’s comprehensive rehabilitation solutions portfolio.

Fourier has developed its very own intelligent healthcare robotics technology platform, RehabHub™, to provide tailored digital healthcare solutions that will revolutionise the neurorehabilitation industry. Using Fourier Intelligence’s RehabHub™ technology and the EXOPS™ platform, UQ and other research groups around the globe are working to ensure advanced technologies provide meaningful, individualised, and effective therapy that is widely applicable and enhances the quality of life of patients worldwide.

For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: marketing.globalhq@fftai.com